Omnova Issues Debt to Fund Eliokem Deal

Omnova will sell $250 million in new bonds to fund its previously announced acquisition of Eliokem from AXA Private Equity, the company has announced. The interest rate and maturation date of the bonds has yet to be disclosed. A new $200 million term loan will also be use to fund the $300 million acquisition, which is expected to be completed by the end of the year. Late last month, Moody's Investors Service (New York) upgraded Omnova's corporate credit rating to 'B1' from 'B2,' though both ratings are speculative-grade, or 'junk.' The upgrade was attributed to...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers